Satellos Bioscience Stock Analysis

Satellos OTC Stock Analysis Notes

About 14.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Satellos Bioscience recorded a loss per share of 0.47. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 18th of August 2021. Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Satellos Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Satellos Bioscience is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Satellos Bioscience contact Francis MBA at 647 660 1780 or learn more at https://satellos.com.

Satellos Bioscience Investment Alerts

Satellos Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Satellos Bioscience's market, we take the total number of its shares issued and multiply it by Satellos Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 10th of February, Satellos Bioscience has the Semi Deviation of 3.4, coefficient of variation of 523.25, and Risk Adjusted Performance of 0.1617. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Satellos Bioscience, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Satellos Bioscience, which can be compared to its competition. Please validate Satellos Bioscience information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Satellos Bioscience is priced more or less accurately, providing market reflects its prevalent price of 11.25 per share. Given that Satellos Bioscience has jensen alpha of 0.9564, we advise you to double-check Satellos Bioscience's current market performance to make sure the company can sustain itself at a future point.

Satellos Bioscience Price Movement Analysis

Satellos Bioscience Predictive Daily Indicators

Satellos Bioscience Forecast Models

Satellos Bioscience's time-series forecasting models are one of many Satellos Bioscience's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Satellos Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Satellos Bioscience Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Satellos Bioscience's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Satellos Bioscience, which in turn will lower the firm's financial flexibility.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Satellos Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Satellos shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Satellos Bioscience. By using and applying Satellos OTC Stock analysis, traders can create a robust methodology for identifying Satellos entry and exit points for their positions.

When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.